Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€42.03

€42.03

-0.900%
-0.38
-0.900%
-
 
11:47 / Tradegate WKN: A0YJW7 / Name: Zealand / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Zealand Pharma A/s Stock

The price for the Zealand Pharma A/s stock decreased slightly today. Compared to yesterday there is a change of -€0.380 (-0.900%).
So far the community has only identified positive things for Zealand Pharma A/s stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Zealand Pharma A/s in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Zealand Pharma A/s vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Zealand Pharma A/s -0.900% -6.853% 6.826% -23.170% -33.714% 22.360% 76.121%
Saniona AB -0.580% -4.022% -13.442% 73.362% -36.548% 137.232% -34.850%
Ocuphire Pharma Inc. -2.260% -3.571% -5.677% 406.448% 156.837% -22.995% -
NanoViricides Inc. -2.670% 23.077% 66.474% 29.730% 54.839% 30.909% -46.389%

News

SAB Biotherapeutics Q1 Earnings Call Highlights
SAB Biotherapeutics Q1 Earnings Call Highlights

SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the

Why 2026 Could Be Another Breakout Year for Rocket Lab
Why 2026 Could Be Another Breakout Year for Rocket Lab

The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past

New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders

BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New